Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3086999
Max Phase: Preclinical
Molecular Formula: C46H71N7O7
Molecular Weight: 834.12
Molecule Type: Small molecule
Associated Items:
ID: ALA3086999
Max Phase: Preclinical
Molecular Formula: C46H71N7O7
Molecular Weight: 834.12
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCC(=O)N[C@H](/C=C/C(=O)N[C@@H](CCCCN)C(=O)N[C@H](/C=C/C(=O)N[C@@H](CCCCN)C(N)=O)Cc1ccc(O)cc1)Cc1ccc(O)cc1
Standard InChI: InChI=1S/C46H71N7O7/c1-2-3-4-5-6-7-8-9-10-17-42(56)50-36(32-34-18-24-38(54)25-19-34)22-28-44(58)53-41(16-12-14-31-48)46(60)51-37(33-35-20-26-39(55)27-21-35)23-29-43(57)52-40(45(49)59)15-11-13-30-47/h18-29,36-37,40-41,54-55H,2-17,30-33,47-48H2,1H3,(H2,49,59)(H,50,56)(H,51,60)(H,52,57)(H,53,58)/b28-22+,29-23+/t36-,37-,40+,41+/m1/s1
Standard InChI Key: IFXUVPZGHIAPMI-GAPDRLRFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 834.12 | Molecular Weight (Monoisotopic): 833.5415 | AlogP: 4.60 | #Rotatable Bonds: 32 |
Polar Surface Area: 251.99 | Molecular Species: BASE | HBA: 9 | HBD: 9 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.12 | CX Basic pKa: 10.55 | CX LogP: 3.50 | CX LogD: 0.15 |
Aromatic Rings: 2 | Heavy Atoms: 60 | QED Weighted: 0.04 | Np Likeness Score: 0.28 |
1. Shankar SS, Benke SN, Nagendra N, Srivastava PL, Thulasiram HV, Gopi HN.. (2013) Self-assembly to function: design, synthesis, and broad spectrum antimicrobial properties of short hybrid E-vinylogous lipopeptides., 56 (21): [PMID:24117107] [10.1021/jm400884w] |
Source(1):